Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine

By Belknap E.B.   Walters L.M.   Kelling C.   Ayers V.K.   Norris J.   McMillen J.   Hayhow C.   Cochran M.   Reddy D.N.   Wright J.   Collins J.K.  

Vaccine, Vol. 17, Iss. 18, 1999-05 ,pp. : 2297-2305

Elsevier

Access to resources Recommend Favorite

An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field

By Bosch J.C.   De Jong M.C.M.   Franken P.   Frankena K.   Hage J.J.   Kaashoek M.J.   Maris-Veldhuis M.A.   Noordhuizen J.P.T.M.   Van der Poel W.H.M.   Verhoeff J.   Weerdmeester K.   Zimmer G.M.   Van Oirschot J.T.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 265-271

Elsevier

Access to resources Recommend Favorite

In vivo properties of a feline herpesvirus type 1 mutant carrying a lacZ insertion at the gI locus of the unique short segment

By Willemse M.J.   Chalmers W.S.K.   Sondermeijer P.J.A.  

Vaccine, Vol. 14, Iss. 1, 1996-01 ,pp. : 1-5

Elsevier

Access to resources Recommend Favorite

Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD

By Gogev S.   Vanderheijden N.   Lemaire M.   Schynts F.   D'Offay J.   Deprez I.   Adam M.   Eloit M.   Thiry E.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1451-1465

Elsevier

Access to resources Recommend Favorite

A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments

By Mars M.H.   de Jong M.C.M.   van Oirschot J.T.  

Vaccine, Vol. 18, Iss. 19, 2000-04 ,pp. : 1975-1981

Elsevier

Access to resources Recommend Favorite